Gilead Sciences, Yipinhong Pharmaceutical and Mass General Brigham Ventures helped the slow-release drug developer secure series C cash bringing its overall funding to almost $250m.

GV participated in a series C round for the fertility and gynaecology services provider at a $612m valuation, doubling its overall funding.

The Gree and Bennett Coleman & Co-backed education software provider boosted its series C round to $65m, with Tiger Global Management leading the deal.

Waste management software provider Recycle Track Systems bagged $35m in a Citi-led series C round while muscular dystrophy drug developer Vita Therapeutics completed a $32m series A.

GV, Latacora and Salesforce Ventures helped the app development technology provider close its latest round, which will support hiring and research and development.

BeiGene helped mRNA therapeutics developer Strand Therapeutics raise $52m while the Afterpay-backed AP Ventures led logistics provider Sendle's $35m series C round.

Eli Lilly, Johnson & Johnson and Pfizer helped drug developer TRexBio close its $59m series A round while Slack backed human resources software provider Oyster at a $475m valuation.

The autonomous vehicle technology developer has disclosed it raised $310m in its latest round, which included corporate joint venture Alliance Ventures.

Bloomberg Beta invested in a round which will fund Primer's NLP product development for the government and commercial sectors.

Lilly Asia Ventures and Baidu Ventures helped the drug discovery software provider push its overall funding past the $310m mark.